First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer
First Patient with Colon Cancer Dosed in a Phase 2 Study of TCMCB07
Radiation Delay in NSCLC May Aid Outcomes, But Raises Toxicity Risks
Radiation Therapy Now More Targeted and Tolerable in GI Cancer